iShares Nasdaq Biotechnology ETF (IBB)
NASDAQ: IBB · IEX Real-Time Price · USD
120.04
+2.03 (1.72%)
Jun 24, 2022 4:00 PM EDT - Market closed
377 Holdings
No. | Symbol | Company Name | % Assets | Shares |
---|---|---|---|---|
1 | GILD | Gilead Sciences | 7.62% | 9,226,264 |
2 | VRTX | Vertex Pharmaceuticals | 7.48% | 2,000,736 |
3 | AMGN | Amgen | 7.48% | 2,330,459 |
4 | REGN | Regeneron Pharmaceuticals | 6.63% | 826,863 |
5 | MRNA | Moderna | 5.10% | 2,699,336 |
6 | IQV | IQVIA Holdings | 3.88% | 1,389,830 |
7 | SGEN | Seagen | 3.28% | 1,426,931 |
8 | BIIB | Biogen | 3.20% | 1,147,455 |
9 | ILMN | Illumina | 3.13% | 1,227,213 |
10 | BNTX | BioNTech SE | 2.65% | 1,515,731 |
11 | MTD | Mettler-Toledo International | 2.62% | 175,517 |
12 | WAT | Waters | 1.99% | 470,238 |
13 | ALNY | Alnylam Pharmaceuticals | 1.82% | 940,557 |
14 | GMAB | Genmab | 1.70% | 4,149,642 |
15 | INCY | Incyte | 1.70% | 1,723,886 |
16 | ARGX | Argenx SE | 1.62% | 337,308 |
17 | BMRN | BioMarin Pharmaceutical | 1.59% | 1,426,623 |
18 | TECH | Bio-Techne | 1.39% | 304,344 |
19 | BGNE | BeiGene | 1.33% | 645,875 |
20 | CRL | Charles River Laboratories International | 1.15% | 395,049 |
21 | UTHR | United Therapeutics | 1.11% | 348,192 |
22 | NBIX | Neurocrine Biosciences | 0.94% | 734,414 |
23 | BHVN | Biohaven Pharmaceutical Holding Co. | 0.93% | 487,966 |
24 | RGEN | Repligen | 0.86% | 404,885 |
25 | SYNH | Syneos Health | 0.74% | 802,743 |
26 | EXEL | Exelixis | 0.69% | 2,465,318 |
27 | BRKR | Bruker | 0.68% | 795,855 |
28 | HALO | Halozyme Therapeutics | 0.66% | 1,071,003 |
29 | NVCR | Novocure | 0.66% | 708,537 |
30 | LEGN | Legend Biotech | 0.64% | 955,208 |
31 | SRPT | Sarepta Therapeutics | 0.62% | 655,418 |
32 | IONS | Ionis Pharmaceuticals | 0.57% | 1,100,291 |
33 | ITCI | Intra-Cellular Therapies | 0.51% | 676,349 |
34 | ALKS | Alkermes | 0.49% | 1,267,485 |
35 | CRSP | CRISPR Therapeutics AG | 0.48% | 558,761 |
36 | APLS | Apellis Pharmaceuticals | 0.43% | 693,140 |
37 | MEDP | Medpace Holdings | 0.43% | 214,599 |
38 | NVAX | Novavax | 0.42% | 610,920 |
39 | ASND | Ascendis Pharma | 0.42% | 345,487 |
40 | TXG | 10X Genomics | 0.41% | 664,676 |
41 | RARE | Ultragenyx Pharmaceutical | 0.40% | 507,759 |
42 | CYTK | Cytokinetics | 0.39% | 629,535 |
43 | ARWR | Arrowhead Pharmaceuticals | 0.36% | 797,701 |
44 | NTLA | Intellia Therapeutics | 0.36% | 534,136 |
45 | MRTX | Mirati Therapeutics | 0.35% | 402,466 |
46 | NTRA | Natera | 0.35% | 681,701 |
47 | BPMC | Blueprint Medicines | 0.34% | 453,389 |
48 | TPTX | Turning Point Therapeutics | 0.33% | 335,669 |
49 | MRVI | Maravai LifeSciences Holdings | 0.32% | 854,993 |
50 | FOLD | Amicus Therapeutics | 0.31% | 2,130,390 |
51 | DNLI | Denali Therapeutics | 0.30% | 764,162 |
52 | GLPG | Galapagos NV | 0.30% | 412,988 |
53 | PTCT | PTC Therapeutics | 0.29% | 544,651 |
54 | ABCM | Abcam | 0.28% | 1,444,664 |
55 | ZLAB | Zai Lab | 0.26% | 601,748 |
56 | KRTX | Karuna Therapeutics | 0.26% | 170,819 |
57 | GRFS | Grifols | 0.26% | 1,649,536 |
58 | BEAM | Beam Therapeutics | 0.24% | 443,974 |
59 | INSM | Insmed | 0.24% | 918,431 |
60 | FATE | Fate Therapeutics | 0.24% | 710,458 |
61 | ACAD | ACADIA Pharmaceuticals | 0.23% | 1,209,693 |
62 | ABCL | AbCellera Biologics | 0.21% | 1,475,341 |
63 | TWST | Twist Bioscience | 0.20% | 400,195 |
64 | GBT | Global Blood Therapeutics | 0.20% | 485,260 |
65 | ARVN | Arvinas | 0.20% | 349,418 |
66 | VIR | Vir Biotechnology | 0.19% | 568,153 |
67 | BCRX | BioCryst Pharmaceuticals | 0.19% | 1,435,811 |
68 | SAGE | Sage Therapeutics | 0.19% | 397,891 |
69 | IRWD | Ironwood Pharmaceuticals | 0.17% | 1,175,377 |
70 | XENE | Xenon Pharmaceuticals | 0.17% | 397,763 |
71 | CCXI | ChemoCentryx | 0.17% | 456,647 |
72 | TVTX | Travere Therapeutics | 0.16% | 469,535 |
73 | ROIV | Roivant Sciences | 0.16% | 2,600,167 |
74 | XNCR | Xencor | 0.16% | 455,425 |
75 | VCYT | Veracyte | 0.16% | 552,153 |
76 | MYGN | Myriad Genetics | 0.15% | 604,222 |
77 | AUPH | Aurinia Pharmaceuticals | 0.15% | 979,491 |
78 | IOVA | Iovance Biotherapeutics | 0.15% | 1,093,282 |
79 | LGND | Ligand Pharmaceuticals | 0.15% | 125,803 |
80 | RLAY | Relay Therapeutics | 0.14% | 575,270 |
81 | ZNTL | Zentalis Pharmaceuticals | 0.14% | 398,717 |
82 | EBS | Emergent BioSolutions | 0.14% | 323,378 |
83 | KRYS | Krystal Biotech | 0.14% | 153,727 |
84 | PRTA | Prothena | 0.13% | 364,787 |
85 | VIVO | Meridian Bioscience | 0.13% | 336,758 |
86 | CDNA | CareDx | 0.13% | 409,707 |
87 | ADPT | Adaptive Biotechnologies | 0.13% | 1,092,761 |
88 | PACB | Pacific Biosciences of California | 0.12% | 1,708,605 |
89 | AGIO | Agios Pharmaceuticals | 0.12% | 425,041 |
90 | FLGT | Fulgent Genetics | 0.12% | 163,004 |
91 | RCUS | Arcus Biosciences | 0.11% | 346,044 |
92 | KURA | Kura Oncology | 0.11% | 494,160 |
93 | OPK | OPKO Health | 0.11% | 3,190,507 |
94 | MDGL | Madrigal Pharmaceuticals | 0.11% | 97,564 |
95 | RVNC | Revance Therapeutics | 0.11% | 532,313 |
96 | ISEE | IVERIC bio | 0.11% | 807,816 |
97 | FGEN | FibroGen | 0.10% | 670,486 |
98 | RGNX | REGENXBIO | 0.10% | 290,544 |
99 | RVMD | Revolution Medicines | 0.10% | 396,164 |
100 | ALLO | Allogene Therapeutics | 0.10% | 617,146 |
101 | IMGN | ImmunoGen | 0.10% | 1,714,719 |
102 | MNKD | MannKind | 0.10% | 1,856,909 |
103 | BBIO | BridgeBio Pharma | 0.10% | 811,215 |
104 | RETA | Reata Pharmaceuticals | 0.10% | 218,326 |
105 | EDIT | Editas Medicine | 0.10% | 536,189 |
106 | ENTA | Enanta Pharmaceuticals | 0.09% | 152,016 |
107 | SNDX | Syndax Pharmaceuticals | 0.09% | 360,371 |
108 | RCKT | Rocket Pharmaceuticals | 0.09% | 477,805 |
109 | CRNX | Crinetics Pharmaceuticals | 0.09% | 338,492 |
110 | CTKB | Cytek Biosciences | 0.09% | 627,343 |
111 | QURE | uniQure | 0.08% | 328,326 |
112 | SWTX | Springworks Therapeutics | 0.08% | 249,171 |
113 | CVAC | CureVac | 0.08% | 425,259 |
114 | ACRS | Aclaris Therapeutics | 0.08% | 400,305 |
115 | n/a | USD CASH | 0.08% | 6,344,382 |
116 | IMAB | I-Mab | 0.08% | 519,469 |
117 | KYMR | Kymera Therapeutics | 0.08% | 315,692 |
118 | PCVX | Vaxcyte | 0.08% | 295,205 |
119 | AVXL | Anavex Life Sciences | 0.08% | 589,742 |
120 | KDNY | Chinook Therapeutics | 0.08% | 322,774 |
121 | NKTR | Nektar Therapeutics | 0.08% | 1,442,463 |
122 | RXRX | Recursion Pharmaceuticals | 0.08% | 644,749 |
123 | AXSM | Axsome Therapeutics | 0.08% | 240,913 |
124 | XTSLA | BLK CSH FND TREASURY SL AGENCY | 0.08% | 5,840,000 |
125 | BLU.TO | BELLUS HEALTH INC | 0.07% | 687,654 |
126 | ARQT | Arcutis Biotherapeutics | 0.07% | 247,835 |
127 | RXDX | Prometheus Biosciences | 0.07% | 190,397 |
128 | MRUS | Merus | 0.07% | 252,890 |
129 | RNA | Avidity Biosciences | 0.07% | 349,300 |
130 | CDXS | Codexis | 0.07% | 497,023 |
131 | ATRA | Atara Biotherapeutics | 0.07% | 703,773 |
132 | QTRX | Quanterix | 0.07% | 264,133 |
133 | DCPH | Deciphera Pharmaceuticals | 0.07% | 365,700 |
134 | ALEC | Alector | 0.07% | 475,029 |
135 | NVTA | Invitae | 0.07% | 1,762,473 |
136 | ITOS | iTeos Therapeutics | 0.06% | 227,455 |
137 | NSTG | NanoString Technologies | 0.06% | 351,991 |
138 | MORF | Morphic Holding | 0.06% | 196,119 |
139 | VNDA | Vanda Pharmaceuticals | 0.06% | 425,813 |
140 | MYOV | Myovant Sciences | 0.06% | 325,314 |
141 | ANAB | AnaptysBio | 0.06% | 192,173 |
142 | NUVB | Nuvation Bio | 0.06% | 1,028,082 |
143 | STVN | Stevanato Group S.p.A. | 0.06% | 260,010 |
144 | CHRS | Coherus BioSciences | 0.06% | 568,405 |
145 | SGMO | Sangamo Therapeutics | 0.06% | 958,207 |
146 | SANA | Sana Biotechnology | 0.05% | 620,520 |
147 | YMAB | Y-mAbs Therapeutics | 0.05% | 279,406 |
148 | CSTL | Castle Biosciences | 0.05% | 185,140 |
149 | RLMD | Relmada Therapeutics | 0.05% | 207,661 |
150 | RDUS | Radius Health | 0.05% | 368,119 |
151 | DSGN | Design Therapeutics | 0.05% | 243,911 |
152 | REPL | Replimune Group | 0.05% | 212,799 |
153 | AVIR | Atea Pharmaceuticals | 0.05% | 565,869 |
154 | NRIX | Nurix Therapeutics | 0.05% | 294,152 |
155 | TBPH | Theravance Biopharma | 0.05% | 420,452 |
156 | GERN | Geron | 0.05% | 2,654,138 |
157 | INO | Inovio Pharmaceuticals | 0.05% | 1,768,290 |
158 | NUVL | Nuvalent | 0.05% | 271,961 |
159 | RAPT | Rapt Therapeutics | 0.05% | 178,912 |
160 | NKTX | Nkarta | 0.05% | 267,307 |
161 | KOD | Kodiak Sciences | 0.04% | 376,033 |
162 | LYEL | Lyell Immunopharma | 0.04% | 495,979 |
163 | ATAI | ATAI Life Sciences | 0.04% | 921,826 |
164 | ALT | Altimmune | 0.04% | 315,119 |
165 | RPTX | Repare Therapeutics | 0.04% | 228,137 |
166 | PTGX | Protagonist Therapeutics | 0.04% | 352,250 |
167 | IDYA | IDEAYA Biosciences | 0.04% | 235,476 |
168 | GOSS | Gossamer Bio | 0.04% | 426,167 |
169 | CARA | Cara Therapeutics | 0.04% | 351,796 |
170 | VERV | Verve Therapeutics | 0.04% | 193,285 |
171 | KROS | Keros Therapeutics | 0.04% | 116,299 |
172 | MRSN | Mersana Therapeutics | 0.04% | 631,804 |
173 | ADMA | ADMA Biologics | 0.04% | 1,469,287 |
174 | DAWN | Day One Biopharmaceuticals | 0.04% | 173,519 |
175 | ABUS | Arbutus Biopharma | 0.04% | 1,020,459 |
176 | ERAS | Erasca | 0.04% | 511,444 |
177 | MIRM | Mirum Pharmaceuticals | 0.04% | 141,314 |
178 | MXCT | MaxCyte | 0.04% | 664,706 |
179 | PMVP | PMV Pharmaceuticals | 0.04% | 225,840 |
180 | ARCT | Arcturus Therapeutics Holdings | 0.04% | 180,195 |
181 | AFMD | Affimed | 0.04% | 1,010,328 |
182 | CMPS | COMPASS Pathways | 0.04% | 266,469 |
183 | COGT | Cogent Biosciences | 0.04% | 292,427 |
184 | BCYC | Bicycle Therapeutics | 0.04% | 178,215 |
185 | KNSA | Kiniksa Pharmaceuticals | 0.04% | 262,146 |
186 | KPTI | Karyopharm Therapeutics | 0.04% | 542,859 |
187 | ZYME | Zymeworks | 0.03% | 411,781 |
188 | TIL | Instil Bio | 0.03% | 487,396 |
189 | GBIO | Generation Bio Co. | 0.03% | 363,470 |
190 | CGEM | Cullinan Oncology | 0.03% | 191,482 |
191 | OLK | Olink Holding AB (publ) | 0.03% | 226,285 |
192 | ICPT | Intercept Pharmaceuticals | 0.03% | 186,879 |
193 | NGM | NGM Biopharmaceuticals | 0.03% | 175,547 |
194 | IBRX | ImmunityBio | 0.03% | 625,143 |
195 | FMTX | Forma Therapeutics Holdings | 0.03% | 334,721 |
196 | KZR | Kezar Life Sciences | 0.03% | 404,062 |
197 | BLUE | Bluebird Bio | 0.03% | 548,667 |
198 | BLI | Berkeley Lights | 0.03% | 401,072 |
199 | IGMS | IGM Biosciences | 0.03% | 123,638 |
200 | JANX | Janux Therapeutics | 0.03% | 170,334 |
As of Jun 23, 2022